GBioLogics is a specialized biopharmaceutical development company that aims to create a healthier future by harnessing the power of bio-medicine. With a strong focus on developing bio-pharmaceuticals, GBioLogics offers a wide range of products and services. Their platform, sGalectin-9 Platform, serves as the foundation for their pipeline, which includes the development of innovative bio-drugs and bio-similars.

With a commitment to research and development, GBioLogics utilizes their state-of-the-art laboratory and collaborates with experienced partners to drive innovation and bring breakthrough therapies to market. In addition to their product development activities, GBioLogics also offers consulting services to provide expert guidance and support to clients in the biopharmaceutical industry. Through their consulting service, they offer a comprehensive scope of expertise and experiences, helping clients navigate the complexities of drug development and commercialization.

To learn more about GBioLogics and their offerings, visit their website or contact them directly. They are located at 242 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, South Korea. GBioLogics is driven by a vision of a world filled with hope for a healthier life, and they strive to make a significant impact in the field of bio-medicine